当前位置:首页 - 行情中心 - 同和药业(300636) - 财务分析

同和药业

(300636)

  

流通市值:30.75亿  总市值:35.15亿
流通股本:3.67亿   总股本:4.20亿

同和药业(300636)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.84亿元,每股收益0.20元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益237580.78万元,未分配利润64231.22万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产325835.12万元,负债88254.34万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入636,241,288.48427,422,152.61186,897,547.53758,890,499.03
营业总成本520,768,052.25341,667,938.34161,677,017.83626,890,162.6
其他经营收益
营业利润91,735,058.464,581,581.9722,045,134.74111,400,839.04
利润总额92,417,400.6264,581,632.9922,045,185.76114,689,908.16
净利润83,664,591.0458,486,512.5720,781,376.97106,584,102.17
每股收益
其他综合收益----
综合收益总额83,664,591.0458,486,512.5720,781,376.97106,584,102.17
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,490,389,022.331,239,075,084.931,164,235,983.151,051,029,837.06
非流动资产:
非流动资产合计1,767,962,182.252,029,409,249.592,257,051,203.282,268,521,835.65
资产总计3,258,351,204.583,268,484,334.523,421,287,186.433,319,551,672.71
流动负债:
流动负债合计582,555,347.13411,224,471.07587,760,063.24505,841,421.41
非流动负债:
非流动负债合计299,988,052.13506,630,136.6503,997,860.39504,962,365.47
负债合计882,543,399.26917,854,607.671,091,757,923.631,010,803,786.88
所有者权益(或股东权益):
归属于母公司股东权益合计2,375,807,805.322,350,629,726.852,329,529,262.82,308,747,885.83
股东权益合计2,375,807,805.322,350,629,726.852,329,529,262.82,308,747,885.83
负债和股东权益合计3,258,351,204.583,268,484,334.523,421,287,186.433,319,551,672.71
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计607,846,011.87420,756,510.11180,880,374.54884,393,804.35
经营活动现金流出小计414,664,396.73292,940,802.88145,216,119.32599,204,109.96
经营活动产生的现金流量净额193,181,615.14127,815,707.2335,664,255.22285,189,694.39
投资活动产生的现金流量:
投资活动现金流入小计467,217,368.12366,493,335.3283,354,339.0977,846,960.03
投资活动现金流出小计435,575,994.9196,032,228.4467,264,490.43583,499,893.25
投资活动产生的现金流量净额31,641,373.22170,461,106.8816,089,848.66-505,652,933.22
筹资活动产生的现金流量:
筹资活动现金流入小计358,014,762.13232,580,000164,580,000891,487,338.8
筹资活动现金流出小计507,117,084.41338,975,044.7985,871,770.281,002,461,092.97
筹资活动产生的现金流量净额-149,102,322.28-106,395,044.7978,708,229.72-110,973,754.17
汇率变动对现金及现金等价物的影响1,405,439.241,613,697.98339,655.944,046,855.02
现金及现金等价物净增加额77,126,105.32193,495,467.3130,801,989.54-327,390,137.98
期末现金及现金等价物余额242,538,343.08358,907,705.06296,214,227.3165,412,237.76
补充资料:
现金及现金等价物的净增加额-193,495,467.3--327,390,137.98
最新报告期:2025-10-25
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
平安证券叶寅,韩盟盟0.240.290.342025-10-25
华创证券郑辰,王宏雨0.310.370.452025-09-03
太平洋周豫,乔露阳0.310.380.472025-08-29
TOP↑